Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004579 · ClinicalTrials.gov registry record · Phase 1
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
A Phase 1 study, sponsored by Walter Reed Army Institute of Research (WRAIR).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004579: Completed Phase 1 study, sponsored by Walter Reed Army Institute of Research (WRAIR).
NCT00004579 is a Phase 1 study that has completed, run by Walter Reed Army Institute of Research (WRAIR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004579, a Phase 1 study, has completed, sponsored by Walter Reed Army Institute of Research (WRAIR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, is safe and can prevent HIV infection. The vCP205 vaccine will be tested with another vaccine, gp160MN/LAI-2.
Interventions
- BIOLOGICAL ALVAC-HIV MN120TMG (vCP205)
- BIOLOGICAL gp160 MN/LAI-2
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-04 |
| Phase | Phase 1 |
What the finished NCT00004579 record still lists
NCT00004579 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which ALVAC-HIV MN120TMG (vCP205) is the first listed.
NCT00004579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004579 about?
NCT00004579 is a clinical study titled "A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection". The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, is safe and can prevent HIV infection. The vCP205 vaccine will be tested with another vaccine, gp160MN/LAI-2.
What is the current status of trial NCT00004579?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-04.
What interventions are being tested in trial NCT00004579?
The interventions under investigation include: ALVAC-HIV MN120TMG (vCP205) (BIOLOGICAL), gp160 MN/LAI-2 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00004579?
This trial is sponsored by Walter Reed Army Institute of Research (WRAIR), which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia